Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Trends in Biotechnology|July 4, 1998
The development of bioengineered skinR S Kirsner, V Falanga, W H EaglsteinArchives of Dermatology|April 1, 1993
The biology of skin grafts. Skin grafts as pharmacologic agentsR S Kirsner, V Falanga, W H EaglsteinDermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 1, 1997
Split-thickness skin grafting for lower extremity ulcerationsR S Kirsner, W H Eaglstein, F A KerdelJournal of the American Academy of Dermatology|April 1, 1993
The clinical spectrum of lipodermatosclerosisR S Kirsner, J B Pardes, W H Eaglstein, et al.Journal of the American Academy of Dermatology|February 24, 2001
Chronic venous insufficiency and venous leg ulcerationI C Valencia, A Falabella, R S Kirsner, et al.Lancet (London, England)|August 10, 1991
Stanozolol in treatment of leg ulcers due to cryofibrinogenaemiaV Falanga, R S Kirsner, W H Eaglstein, et al.Journal of the American Academy of Dermatology|January 1, 1993
Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemiaR S Kirsner, W H Eaglstein, M H Katz, et al.The British Journal of Dermatology|August 1, 1996
Skin grafts as pharmacological agents: pre-wounding of the donor siteR S Kirsner, V Falanga, F A Kerdel, et al.Journal of the American Academy of Dermatology|December 1, 1991
Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growthM H Katz, A F Alvarez, R S Kirsner, et al.Pageof 16